Ivermectin & mild illness
The antiparasitic ivermectin does not seem to improve outcomes in mild COVID-19, according to a randomized, single-center trial in JAMA. Previous research has suggested a potential effect against SARS-CoV-2. In … Read More
The antiparasitic ivermectin does not seem to improve outcomes in mild COVID-19, according to a randomized, single-center trial in JAMA. Previous research has suggested a potential effect against SARS-CoV-2. In … Read More
The number of children infected with SARS-CoV-2 in Mississippi could be 13 times higher than reported, according to a seroprevalence study in MMWR. Researchers performed SARS-CoV-2 antibody testing on some 1600 … Read More
Among 91 patients hospitalized with COVID-19 in Italy who had conjunctival swab specimens taken for PCR testing, 57% had positive test results. Overall, conjunctival swabs were positive from one … Read More
In JAMA Cardiology, U.S. researchers report on cardiac findings in professional athletes after COVID-19. Nearly 800 pro athletes who tested positive for COVID-19 underwent return-to-play cardiac screening — troponin testing, … Read More
Over 2600 cases of multisystem inflammatory syndrome in children (MIS-C) were reported to the CDC between May 2020 and March 2021. The agency notes that the number passed 1000 … Read More
The National Institutes of Health COVID-19 Treatment Guidelines Panel now recommends the interleukin-6 inhibitor tocilizumab (in addition to a corticosteroid) for certain hospitalized patients with COVID-19. In a guideline … Read More
The CDC has issued its first set of guidelines for people who have been fully vaccinated against COVID-19. The guidelines allow them to resume some lower-risk activities. Among the … Read More
In Obstetrics and Gynecology, researchers report on a case of transplacental transfer of neutralizing SARS-CoV-2 antibodies after vaccination during pregnancy. A woman received both doses of the Pfizer-BioNTech vaccine during … Read More
Of nearly 65,000 employees of a Boston hospital system who received their first dose of the Pfizer-BioNTech or Moderna mRNA vaccine during the first 2 months of U.S. vaccinations, … Read More
Summary of recent changes (last updated March 3, 2021):Clinical considerations added for use of Janssen (Johnson & Johnson) COVID-19 vaccine.Updated recommendations for fully vaccinated people who subsequently develop COVID-19.Updated … Read More